rosiglitazone has been researched along with neferine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, B; Chen, L; Pan, Y; Wang, K; Wang, S; Xu, B; Yu, X; Zhou, S | 1 |
| Fan, B; Li, G; Liang, S; Liu, S; Peng, H; Qin, S; Qiu, S; Tu, G; Xu, H; Xu, W; Yu, S; Zheng, C; Zhu, Q; Zhu, S | 1 |
2 other study(ies) available for rosiglitazone and neferine
| Article | Year |
|---|---|
Neferine enhances insulin sensitivity in insulin resistant rats.
Topics: Animals; Anti-Obesity Agents; Benzylisoquinolines; Blood Glucose; Female; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Resistance; Nelumbo; Obesity; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Rosiglitazone; Seeds; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha | 2009 |
Effects of neferine on CCL5 and CCR5 expression in SCG of type 2 diabetic rats.
Topics: Analysis of Variance; Animals; Benzylisoquinolines; Blood Glucose; Blood Pressure; Chemokine CCL5; Diabetes Mellitus, Experimental; Disease Models, Animal; Fasting; Female; Gene Expression Regulation; Heart Rate; Hypoglycemic Agents; Insulin; Lipid Metabolism; Lipoproteins, HDL; Male; Neural Conduction; Rats; Rats, Sprague-Dawley; Receptors, CCR5; RNA, Messenger; Rosiglitazone; Superior Cervical Ganglion; Thiazolidinediones | 2013 |